Prosecution Insights
Last updated: April 19, 2026

Nanjing Zaiming Pharmaceutical Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18260004 TRICYCLIC COMPOUND AND USE THEREOF STOCKTON, LAURA LYNNE 1626 Non-Final OA Jun 29, 2023
18265591 Anti-Human MSLN Antibody And Application Thereof DUNN, LINDSAY MICHELLE 1644 Non-Final OA Jun 06, 2023

Managing Nanjing Zaiming Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month